Home
>
National Drug Code (NDC)
>
Lotensin HCT
Lotensin HCT - 0078-0454-05 - (benazepril hydrochloride and hydrochlorothiazide)
Drug Information of Lotensin HCT
| Product NDC: | 0078-0454 |
| Proprietary Name: | Lotensin HCT |
| Non Proprietary Name: | benazepril hydrochloride and hydrochlorothiazide |
| Active Ingredient(s): | 20; 25 mg/1; mg/1 & nbsp; benazepril hydrochloride and hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lotensin HCT
| Product NDC: | 0078-0454 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020033 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19920530 |
Package Information of Lotensin HCT
| Package NDC: | 0078-0454-05 |
| Package Description: | 100 TABLET in 1 BOTTLE (0078-0454-05) |
NDC Information of Lotensin HCT
| NDC Code | 0078-0454-05 |
| Proprietary Name | Lotensin HCT |
| Package Description | 100 TABLET in 1 BOTTLE (0078-0454-05) |
| Product NDC | 0078-0454 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | benazepril hydrochloride and hydrochlorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19920530 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| Strength Number | 20; 25 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
